Bicara Therapeutics (BCAX) CFO Jennifer Larson submits initial Form 3
Bicara Therapeutics Inc.'s Chief Financial Officer, Jennifer Larson, has submitted an initial Form 3, indicating her status as an officer but showing no reportable equity holdings or transactions at this time. The filing includes a reference to an attached Exhibit 24, which grants a …